The Impact Of Treatment Adherence On Clinical And Economic Outcomes In Multiple Sclerosis: Real-World Evidence From Alberta, Canada
VALUE IN HEALTH(2016)
Abstract
•Of Albertan MS patients identified, 66% were adherent to their prescribed DMT.•Adherent patients had ~ 20% less physician and ambulatory care visits than non-adherent patients.•Adherent patients had ~ 50% fewer hospitalizations than non-adherent patients.•These results highlight a significant impact of adherence to DMTs on healthcare utilization.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined